Awaiting development: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Type 1 selected

Type

Guidance programme

Showing 1 to 2 of 2

TitleType
Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]Technology appraisal guidance
Iclepertin for treating cognitive impairment associated with schizophrenia ID6483Technology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All